PTC Therapeutics, Inc. (PTCT)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-07-30) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-07) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-02-19) · 99.1 | 8-K (2026-01-12) · 99.1 · 99.2 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-04) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-07) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-06) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-02-27) · 99.1 | 8-K (2025-01-13) · 99.1 · 99.2 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-07) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-08) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-04-25) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-02-29) · 99.1 | 8-K (2024-01-08) · 99.1 · 99.2 | ||
| 10-Q | Q3-2023 | 8-K (2023-10-26) · 99.1 | ||
| 10-K/A | FY-2022 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Consolidated Statements of Comprehensive (loss) Income | — |
|
| Consolidated Statements of Comprehensive Income (loss) | ||
| Consolidated Statements of Comprehensive Loss | ||
| Consolidated Statements of Stockholders' (deficit) | — |
|
| Consolidated Statements of Stockholders' (deficit) Equity | ||
| Consolidated Statements of Stockholders' Deficit | ||
| Consolidated Statements of Stockholders' Equity/(deficit) | — |
|
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| 401(k) Plan | — |
|
| Accounts Payable and Accrued Expenses | ||
| Capital Structure | ||
| Capitalization | — |
|
| Commitments and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Debt | ||
| Fair Value of Financial Instruments and Investments | ||
| Fair Value of Financial Instruments and Marketable Securities | — |
|
| Fixed Assets | — |
|
| Geographic Information | — |
|
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | ||
| Intangible Assets and Goodwill | ||
| Inventory | — |
|
| Leases | ||
| Net (loss) Income Per Share | — |
|
| Net Income (loss) Per Share | ||
| Net Loss Per Share | ||
| Other Comprehensive Income (loss) and Accumulated Other Comprehensive Items | — |
|
| Pay Vs Performance Disclosure | ||
| Revenue Recognition | ||
| Segment and Geographic Information | — |
|
| Segment Information | — |
|
| Stock Award Plan | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||
| The Company | ||